Prozkoumejte nejčtenější články a videa na Campus Sanofi
We would like to update you on a recently published randomized, head-to-head, open label phase 3 trial in Chinese people with Type 2 Diabetes Mellitus suboptimally controlled on OADs entitled the Soli-D study.